Multiparametric transrectal ultrasound and photoacoustic imaging of human prostate

人前列腺多参数经直肠超声和光声成像

基本信息

项目摘要

ABSTRACT Prostate cancer (PCa), with an annually increasing incident rate, has become the most commonly diagnosed cancer in American men. The accurate diagnosis of aggressive PCa is critical for the survival of patients. Transrectal ultrasound (TRUS) guided biopsy, the current standard procedure for evaluating the presence and aggressiveness of PCa, suffers from low core yield, leading to under-sampling and under-grading of clinically significant tumors. To fill the long-standing technical gap in PCa diagnosis, we propose to develop a novel multimodal imaging platform which integrates the emerging photoacoustic (PA) imaging technique with the established transrectal ultrasound (TRUS) for multiparametric PCa diagnosis and grading. With the unique capability to map structural/anatomical, mechanical, functional, and molecular information reflecting pathological conditions over the entire human prostate in vivo, non-invasively, the proposed TRUS and PA (i.e. TRUSPA) multiparametric imaging can sensitively detect spatially distributed prostate tumors and, more importantly, differentiate aggressive tumors from non-aggressive ones. Hence, multiparametric TRUSPA (mpTRUSPA), when performed in the same way as in current TRUS, could largely improve the guidance of biopsy sampling by ensuring highly effective core extraction within the most aggressive malignant regions of the prostate. The central hypothesis is that real-time mpTRUSPA imaging – displaying B-mode US based structural information, Power Doppler US based vascular flow, shear wave elastography (SWE) based tissue stiffness, and spectral PA images for mapping hypoxia and angiogenesis - can sensitively characterize cancer aggressiveness in vivo by mapping a group of structural, mechanical, and functional biomarkers of PCa, and can subsequently guide the biopsy sampling. This hypothesis will be objectively and rigorously examined via the proposed studies on clinically relevant PCa animal models and human subjects using the following specific aims: Aim 1: Develop and validate mpTRUSPA imaging system using studies on durable prostate mimicking phantoms and mouse models of aggressive and non-aggressive PCa. Aim 2: Develop and validate an artificial intelligence (AI) framework capable of signal denoising and localization, prostate segmentation, artifact correction, and spectral unmixing of deep tissue PAI signals in real-time. Aim 3: Validate a set of PCa imaging biomarkers that are accessible in vivo by the AI enhanced mpTRUSPA imaging system in a clinical setting. Once the performance of mpTRUSPA imaging of PCa is validated via the proposed studies on animal models and human subjects, this affordable and user-friendly technology will be ready for appropriate phase I/II clinical trials in the next funding cycle. TRUSPA, with the unique capability of detecting and differentiating clinically significant PCa non-invasively, in real time, can seamlessly fit into the current clinical procedure of image-guided biopsy, and holds great potential to shift the paradigm of PCa diagnosis.
抽象的 前列腺癌(PCA)每年增加入射率,已成为最常见的诊断 美国男性的癌症。侵略性PCA的准确诊断对于患者的存活至关重要。 经直肠超声(TRUS)引导活检,这是评估存在和的当前标准程序 PCA的侵略性,核心产量低,导致临床上的采样和上层 重要的肿瘤。为了填补PCA诊断中的长期技术空白,我们建议开发一种小说 多模式成像平台将新兴的光声(PA)成像技术与 用于多参数PCA诊断和分级的转直直肠超声(TRU)。与独特 绘制结构/解剖学,机械,功能和分子信息的能力,反映了病理 整个人类前列腺的条件在体内,非侵入性,拟议的trus和pa(即truspa) 多参数成像可以灵敏地检测空间分布的前列腺肿瘤,更重要的是 将侵袭性肿瘤与非侵入性肿瘤区分开。因此,多参数truspa(mptruspa), 当以与当前TRU中相同的方式执行时,可以在很大程度上通过 确保前列腺最具侵略性的恶性区域内的高效核心提取。 中心假设是实时MPTRUSPA成像 - 显示基于B模式的结构 信息,基于US的动力多普勒血管流,基于剪切波弹性图(SWE)的组织刚度, 用于映射缺氧和血管生成的光谱PA图像 - 可以灵敏地表征癌症 通过映射PCA的一组结构,机械和功能生物标志物,并在体内进行侵略性 随后可以指导活检采样。该假设将通过 提出了针对临床相关的PCA动物模型和人类受试者的拟议研究:使用以下特定目的: AIM 1:使用模仿PROSTATE的研究来开发和验证MPTRUSPA成像系统 以及侵略性和非攻击性PCA的鼠标模型。目标2:开发和验证人工智能 (AI)能够信号定位和定位,前列腺分割,伪影校正和 实时对深组织PAI信号的光谱拆解。目标3:验证一组PCA成像生物标志物 在临床环境中,AI增强的MPTRUSPA成像系统可以在体内访问。 一旦通过对动物模型的拟议研究验证了PCA的MPTRUSPA成像 和人类受试者,这项负担得起且用户友好的技术将准备好进行适当的I/II期临床 在下一个资金周期中进行的试验。 TRUSPA,具有检测和临床区分的独特能力 实时非侵入性的PCA可以无缝地适合当前图像引导的临床程序 活检,并具有改变PCA诊断范式的巨大潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sri Rajasekhar Kothapalli其他文献

Sri Rajasekhar Kothapalli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sri Rajasekhar Kothapalli', 18)}}的其他基金

Clinical Translation of dual-modality transrectal ultrasound and photoacoustic imaging for detection of aggressive human prostate cancer
双模态经直肠超声和光声成像检测侵袭性人类前列腺癌的临床转化
  • 批准号:
    10802712
  • 财政年份:
    2023
  • 资助金额:
    $ 38.69万
  • 项目类别:
A portable photoacoustic imager for diagnosing vascular diseases
用于诊断血管疾病的便携式光声成像仪
  • 批准号:
    10058614
  • 财政年份:
    2020
  • 资助金额:
    $ 38.69万
  • 项目类别:
A portable photoacoustic imager for diagnosing vascular diseases
用于诊断血管疾病的便携式光声成像仪
  • 批准号:
    10265537
  • 财政年份:
    2020
  • 资助金额:
    $ 38.69万
  • 项目类别:
TRANSRECTAL ULTRASOUND AND PHOTOACOUSTIC IMAGING OF PROSTATE AND MOLECULAR IMAGIN
前列腺的经直肠超声和光声成像以及分子成像
  • 批准号:
    8618815
  • 财政年份:
    2014
  • 资助金额:
    $ 38.69万
  • 项目类别:

相似海外基金

Ultrasound-guided Ultra-steerable Histotripsy Array System for Non-invasive treatment of Soft Tissue Sarcoma
超声引导超可控组织解剖阵列系统用于软组织肉瘤的无创治疗
  • 批准号:
    10649994
  • 财政年份:
    2023
  • 资助金额:
    $ 38.69万
  • 项目类别:
Novel Piezoelectric Amino-acid Ultrasound Transducer to Deliver Drugs Through the Blood Brain Barrier
新型压电氨基酸超声换能器通过血脑屏障输送药物
  • 批准号:
    10636328
  • 财政年份:
    2023
  • 资助金额:
    $ 38.69万
  • 项目类别:
Orthognathic speech pathology: Understanding how jaw disharmonies and their surgical correction influence speech
正颌言语病理学:了解下颌不和谐及其手术矫正如何影响言语
  • 批准号:
    10301902
  • 财政年份:
    2021
  • 资助金额:
    $ 38.69万
  • 项目类别:
Physiological and Perceptual Assessment of Hearing in Noise in Nonhuman Primates Following Noise-Induced Cochlear Synaptopathy
噪声引起的耳蜗突触病后非人类灵长类动物噪声听力的生理和知觉评估
  • 批准号:
    10312287
  • 财政年份:
    2021
  • 资助金额:
    $ 38.69万
  • 项目类别:
Orthognathic speech pathology: Understanding how jaw disharmonies and their surgical correction influence speech
正颌言语病理学:了解下颌不和谐及其手术矫正如何影响言语
  • 批准号:
    10673772
  • 财政年份:
    2021
  • 资助金额:
    $ 38.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了